Dark

IRIX
Iridex Corp
stock NASDAQ

At Close

Jul 16, 2026 3:58:35 PM EDT

0.9500USD-9.410%(-0.1000)262,469

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Jul 16, 2026 9:28:30 AM EDT

0.9100USD-13.333%(-0.1400)33,326

After-hours

Jul 15, 2026 4:00:30 PM EDT

1.05USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 11, 2022

04:06PM EST Iridex Sees Q4 2021 Revenue $15.1M-$15.3M Vs $14.01M Est; Sees FY21 Revenue $53.7M-$53.9M Vs $52.64M Est Benzinga

04:05PM EST Iridex Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year ended January 1, 2022. GlobeNewswire Inc

Nov 12, 2021

08:00AM EST Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming 2021 Stifel Virtual Healthcare Conference. GlobeNewswire Inc

Nov 11, 2021

04:18PM EST Iridex Q3 EPS $(0.14), Inline, Sales $13.30M Beat $11.90M Estimate; Raises FY21 Sales Guidance From $50M-$52M To $52M-$53M vs $51.5M Est. Benzinga

04:05PM EST Iridex Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended October 2, 2021. GlobeNewswire Inc

03:55AM EST Earnings Scheduled For November 11, 2021 Benzinga

Nov 6, 2021

12:44PM EDT An international expert consensus panel will discuss best practices in dosing and patient selection using MicroPulse TLT on November 6, 2021 GlobeNewswire Inc

Oct 13, 2021

01:38PM EDT Clinical Data Published in the Journal of Cardiovascular Electrophysiology Could Be Important for This Stock Benzinga

Sep 30, 2021

04:05PM EDT Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming Lytham Partners Fall 2021 Investor Conference. GlobeNewswire Inc

Sep 29, 2021

10:36AM EDT How Good Are Iridex's Earnings? | Return On Capital Employed Benzinga

Aug 12, 2021

05:30PM EDT Iridex: Q2 Earnings Insights Benzinga

05:03PM EDT Iridex Q2 EPS $0.09 Beats $(0.15) Estimate, Sales $13.40M Beat $11.61M Estimate Benzinga

04:05PM EDT Achieved 116% Year-over-Year Revenue Growth and Record Cyclo G6 Probe SalesIncreases Full Year 2021 Guidance GlobeNewswire Inc

04:14AM EDT Earnings Scheduled For August 12, 2021 Benzinga

Aug 9, 2021

04:05PM EDT IRIDEX Corporation (Nasdaq: IRIX),a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming H.C. Wainwright Ophthalmology Virtual Conference. GlobeNewswire Inc

Jul 9, 2021

04:37PM EDT IRIDEX Files For Shelf Of Up To 1.6M Shares Benzinga

Jun 17, 2021

10:00AM EDT Looking Into Iridex's Return On Capital Employed Benzinga

Jun 2, 2021

09:55AM EDT Return On Capital Employed Overview: Iridex Benzinga

May 12, 2021

11:32AM EDT Roth Capital Maintains Buy on Iridex, Raises Price Target to $11 Benzinga

May 11, 2021

04:38PM EDT Recap: Iridex Q1 Earnings Benzinga

04:36PM EDT Iridex Sees FY21 Sales $48M-$51M Vs $50.74M Estimates Benzinga

04:36PM EDT Iridex Sees FY21 $48M-$51M Vs $50.74M Estimates Benzinga

04:33PM EDT Iridex Q1 EPS $(0.14), Inline, Sales $11.96M Beat $9.90M Estimate Benzinga

04:05PM EDT Iridex Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 3, 2021. GlobeNewswire Inc

12:47PM EDT Earnings Scheduled For May 11, 2021 Benzinga

Apr 27, 2021

04:05PM EDT Iridex to Report First Quarter 2021 Financial Results on May 11, 2021 GlobeNewswire Inc

Mar 22, 2021

05:43PM EDT Iridex: Q4 Earnings Insights Benzinga

04:10PM EDT Iridex Q4 EPS $(0.01) Beats $(0.10) Estimate, Sales $12.30M Beat $12.26M Estimate Benzinga

04:08PM EDT Iridex Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended January 2, 2021. GlobeNewswire Inc

03:33AM EDT Earnings Scheduled For March 22, 2021 Benzinga

Mar 19, 2021

10:46AM EDT Preview: Iridex's Earnings Benzinga

Mar 10, 2021

04:05PM EST Iridex Completes Transaction with Topcon Corporation GlobeNewswire Inc

Mar 8, 2021

04:05PM EST Iridex to Report Fourth Quarter and Full Year 2020 Financial GlobeNewswire Inc

Mar 3, 2021

12:29PM EST Roth Capital Maintains Buy on Iridex, Raises Price Target to $9 Benzinga

Mar 2, 2021

04:58PM EST Iridex Corp. (IRIX), a provider of ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, Tuesday said Topcon Corp. will invest in the company by acquiring 10% stake. RTTNews

04:12PM EST Iridex Announces Strategic Collaboration with Topcon Corporation; Transaction Provides $19.5M Cash to Iridex Benzinga

04:05PM EST -- Transaction provides $19.5 million cash to Iridex, as two leaders join forces in glaucoma andretinal disease treatment -- Iridex to host a conference call presentation on March 2, 2021 at 2:00 p.m. PT/5:00 p.m. ET GlobeNewswire Inc

Jan 13, 2021

09:09AM EST Roth Capital Maintains Buy on Iridex, Raises Price Target to $6 Benzinga

Jan 11, 2021

05:18PM EST VOXX International Corp. (VOXX) - Shares of the electronics company surged 30% in extended trading session on Monday after the company reported strong third-quarter results. Third-quarter profit rose to $18.3 million or $0.74 per share from $2.2 million or $0.10 per share last year. Sales surged 82.6% to $201.1 million from $110.1 million last year. RTTNews

05:06PM EST Shares of Iridex Corp. (IRIX) jumped 25% in extended trading session on Monday after the medical devices maker issued a strong outlook for the fourth-quarter and full-year 2020. RTTNews

04:08PM EST IRIDEX Sees Q4 2020 Revs. $12.2M-$12.4M Vs Est $9.42M-$9.8M Benzinga

04:05PM EST IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary unaudited operational and financial results for the fourth quarter and full year ended January 2, 2021. GlobeNewswire Inc

Dec 22, 2020

04:07PM EST IRIDEX Reports MicroPulse Transscleral Laser Therapy Now Accepted In European Glaucoma Society Guidelines Benzinga

04:05PM EST -- Guidelines provide recommendations on the diagnosis and management of glaucoma within the EU -- Nine MicroPulse TLT studies presented at the annual EGS meeting supporting its safety, effectiveness, and versatility in the treatment of glaucoma GlobeNewswire Inc

Nov 9, 2020

04:29PM EST Iridex Q3 EPS $(0.12) Beats $(0.17) Estimate, Sales $8.80M Beat $7.79M Estimate Benzinga

04:05PM EST IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 26, 2020. GlobeNewswire Inc

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 6, 2020

10:19AM EST Earnings Outlook For Iridex Benzinga

Nov 3, 2020

04:05PM EST IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Virtual Healthcare Conference. GlobeNewswire Inc

Oct 26, 2020

04:05PM EDT IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter of 2020 after the close of trading on Monday, November 9, 2020. The Companys management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. GlobeNewswire Inc

Aug 6, 2020

04:48PM EDT Iridex Q2 EPS $(0.20) Beats $(0.22) Estimate, Sales $6.20M Beat $5.94M Estimate Benzinga

Jul 23, 2020

04:05PM EDT IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2020 after the close of trading on Thursday, August 6, 2020. The Companys management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. GlobeNewswire Inc

document.getElementById("mH4zNy").onerror = function(){this.style.display='none';}; .dark-mode .sx8rt3{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .sx8rt3{ color: #333333; background-color: white; border: 2px solid #333333; }IRIXIridex Corpstock NASDAQ

IRIX
Iridex Corp
stock NASDAQ